D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
Rocky Brands
RCKY
$351M
| $2.63M | ﹤0.01% |
63,844
-26,953
| -30% | -$1.05M |
2023 Q4
10 quarters
|
|
2852
Digimarc Corp
DMRC
$164M
| $2.63M | ﹤0.01% |
320,204
-11,205
| -3% | -$105K |
2017 Q3
35 quarters
|
|
2853
PUT
NuScale Power
SMR
$2.21B
| $2.63M | ﹤0.01% |
262,400
+48,700
| +23% | +$549K |
2024 Q4
6 quarters
|
|
2854
Amplify Energy
AMPY
$190M
| $2.63M | ﹤0.01% |
660,670
+338,641
| +105% | +$1.74M |
2025 Q3
3 quarters
|
|
2855
iShares S&P 500 Growth ETF
IVW
$75.5B
| $2.63M | ﹤0.01% |
+19,116
| New | +$2.52M |
2026 Q2
0 quarters
|
|
2856
CALL
International Paper
IP
$17.6B
| $2.63M | ﹤0.01% |
69,000
-41,300
| -37% | -$1.41M |
2024 Q2
8 quarters
|
|
2857
Lincoln International
LCLN
$820M
| $2.63M | ﹤0.01% |
+110,000
| New | +$2.6M |
2026 Q2
0 quarters
|
|
2858
CALL
Flex
FLEX
$28.3B
| $2.63M | ﹤0.01% |
16,200
| – | – |
2025 Q3
3 quarters
|
|
2859
CALL
Ambarella
AMBA
$2.94B
| $2.63M | ﹤0.01% |
30,600
-800
| -3% | -$55.1K |
2025 Q2
4 quarters
|
|
2860
Edgewell Personal Care
EPC
$1.29B
| $2.62M | ﹤0.01% |
97,658
-44,739
| -31% | -$954K |
2022 Q4
14 quarters
|
|
2861
CALL
GeneDx Holdings
WGS
$1.67B
| $2.62M | ﹤0.01% |
38,200
+6,900
| +22% | +$392K |
2024 Q4
6 quarters
|
|
2862
PUT
Celanese
CE
$5.24B
| $2.62M | ﹤0.01% |
57,000
-5,000
| -8% | -$289K |
2025 Q3
3 quarters
|
|
2863
Lands' End
LE
$283M
| $2.61M | ﹤0.01% |
248,700
+184,111
| +285% | +$2.12M |
2021 Q4
18 quarters
|
|
2864
PUT
SL Green Realty
SLG
$3.55B
| $2.6M | ﹤0.01% |
50,300
| – | – |
2024 Q3
7 quarters
|
|
2865
CALL
Galicia Financial Group
GGAL
$6.09B
| $2.6M | ﹤0.01% |
51,900
| – | – |
2026 Q1
1 quarter
|
|
2866
CALL
Ligand Pharmaceuticals
LGND
$6.05B
| $2.59M | ﹤0.01% |
8,200
+1,600
| +24% | +$377K |
2025 Q3
3 quarters
|
|
2867
Tuya Inc
TUYA
$1.01B
| $2.58M | ﹤0.01% |
1,467,653
-592,272
| -29% | -$1.29M |
2022 Q1
17 quarters
|
|
2868
CALL
Vicor
VICR
$8.12B
| $2.58M | ﹤0.01% |
6,800
-5,600
| -45% | -$1.53M |
2025 Q4
2 quarters
|
|
2869
First Tracks Biotherapeutics
TRAX
$1.57B
| $2.58M | ﹤0.01% |
+128,130
| New | +$2.4M |
2026 Q2
0 quarters
|
|
2870
CALL
Unilever
UL
$143B
| $2.57M | ﹤0.01% |
42,800
-62,116
| -59% | -$3.59M |
2025 Q3
3 quarters
|
|
2871
CALL
FuelCell Energy
FCEL
$888M
| $2.57M | ﹤0.01% |
+71,400
| New | +$1.16M |
2026 Q2
0 quarters
|
|
2872
PUT
Gartner
IT
$14.5B
| $2.57M | ﹤0.01% |
19,800
+4,000
| +25% | +$602K |
2025 Q3
3 quarters
|
|
2873
Puma Biotechnology
PBYI
$569M
| $2.57M | ﹤0.01% |
316,343
-34,892
| -10% | -$255K |
2024 Q3
7 quarters
|
|
2874
Neuropace
NPCE
$443M
| $2.56M | ﹤0.01% |
161,081
+117,456
| +269% | +$1.89M |
2026 Q1
1 quarter
|
|
2875
Marcus & Millichap
MMI
$1.04B
| $2.56M | ﹤0.01% |
82,106
-82,279
| -50% | -$2.36M |
2025 Q1
5 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.